Big Move For BioCryst Pharmaceuticals, Inc.
Mon, Jan 10, 2022 at 05:30 PM
BioCryst Pharmaceuticals, Inc. (BCRX:NASDAQ) jumped higher at $14.78, a gain of 27.9%. On Fri, Jan 07, 2022, BCRX:NASDAQ hit a New 2-Week Low of $11.56. The stock got featured on our News Catalysts scanner on Mon, Jan 10, 2022 at 07:13 AM in the 'BIOTECH' category. From Mon, Dec 27, 2021, the stock recorded 44.44% Up Days and 40.00% Green Days
About BioCryst Pharmaceuticals, Inc. (BCRX:NASDAQ)
Biocryst Pharmaceuticals Inc is a pharmaceutical company that designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in the infectious and inflammatory diseases. It has its focus on oral treatments for rare diseases.
Top 10 Gainers:
- Zynga Inc. (ZNGA:NASDAQ), 40.67%
- MOLN (MOLN:NASDAQ), 30.46%
- RXST (RXST:NASDAQ), 28.21%
- BioCryst Pharmaceuticals, Inc. (BCRX:NASDAQ), 27.85%
- iRhythm Technologies, Inc. (IRTC:NASDAQ), 27.55%
- Adamis Pharmaceuticals Corporation (ADMP:NASDAQ), 26.96%
- APR (APR:NASDAQ), 26.11%
- Pluristem Therapeutics Inc. (PSTI:NASDAQ), 24.49%
- OLK (OLK:NASDAQ), 23.8%
- BFRI (BFRI:NASDAQ), 22.03%